UID:
almahu_9949241893502882
Umfang:
X, 538 p. 40 illus., 37 illus. in color.
,
online resource.
Ausgabe:
1st ed. 2022.
ISBN:
9783030860769
Serie:
Handbook of Experimental Pharmacology, 270
Inhalt:
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .
Anmerkung:
Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
In:
Springer Nature eBook
Weitere Ausg.:
Printed edition: ISBN 9783030860752
Weitere Ausg.:
Printed edition: ISBN 9783030860776
Weitere Ausg.:
Printed edition: ISBN 9783030860783
Sprache:
Englisch
DOI:
10.1007/978-3-030-86076-9
URL:
https://doi.org/10.1007/978-3-030-86076-9
Bookmarklink
